This company has been acquired
De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
Vapotherm Toekomstige groei
Future criteriumcontroles 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Vapotherm.
Belangrijke informatie
n/a
Groei van de winst
n/a
Groei van de winst per aandeel
| Medical Equipment winstgroei | 17.6% |
| Inkomstengroei | n/a |
| Toekomstig rendement op eigen vermogen | n/a |
| Dekking van analisten | None |
| Laatst bijgewerkt | n/a |
Recente toekomstige groei-updates
Recent updates
Vapotherm announces $23M private placement
Feb 08Vapotherm GAAP EPS of -$0.98 misses by $0.20, revenue of $13.5M misses by $3.02M
Nov 02Vapotherm draws downgrade at William Blair after 2Q results
Aug 04Vapotherm: Out Of Air
May 11Is Vapotherm (NYSE:VAPO) Using Too Much Debt?
Jan 24
Vapotherm: Hardly Breathing Room
Jul 11Health Check: How Prudently Does Vapotherm (NYSE:VAPO) Use Debt?
May 10Vapotherm reports Q1 results
May 05The Independent Director of Vapotherm, Inc. (NYSE:VAPO), Anthony Arnerich, Just Bought 59% More Shares
Mar 12Announcing: Vapotherm (NYSE:VAPO) Stock Increased An Energizing 225% In The Last Year
Mar 11Does Vapotherm (NYSE:VAPO) Have A Healthy Balance Sheet?
Jan 19
Vapotherm guides Q4 revenue above consensus, ~212% Y/Y growth
Jan 13Thomas Smith of Vapotherm, Inc. (NYSE:VAPO) Just Spent US$217k On Shares
Dec 14Investors Who Bought Vapotherm (NYSE:VAPO) Shares A Year Ago Are Now Up 132%
Dec 11Vapotherm shares +9% on higher Q4 guidance
Dec 01Vapotherm: The Game Has Completely Changed
Nov 13In dit gedeelte presenteren we gewoonlijk prognoses voor de omzet- en winstgroei op basis van de consensusramingen van professionele analisten om beleggers te helpen begrijpen in hoeverre het bedrijf in staat is winst te genereren. Maar omdat Vapotherm onvoldoende gegevens uit het verleden heeft verstrekt en geen analistenprognose heeft, kan de toekomstige winst niet betrouwbaar worden berekend door gegevens uit het verleden te extrapoleren of analistenprognoses te gebruiken.
Dit is een vrij zeldzame situatie, aangezien 97% van de bedrijven die worden gedekt door SimplyWall St wel financiële gegevens uit het verleden hebben.
Winst- en omzetgroeiprognoses
| Datum | Inkomsten | Inkomsten | Vrije kasstroom | Geldmiddelen uit operationele activiteiten | Gem. Aantal analisten |
|---|---|---|---|---|---|
| 6/30/2024 | 71 | -54 | -21 | -17 | N/A |
| 3/31/2024 | 70 | -55 | -24 | -21 | N/A |
| 12/31/2023 | 69 | -58 | -27 | -24 | N/A |
| 9/30/2023 | 68 | -69 | -37 | -31 | N/A |
| 6/30/2023 | 66 | -81 | -54 | -47 | N/A |
| 3/31/2023 | 63 | -108 | -69 | -60 | N/A |
| 12/31/2022 | 67 | -113 | -92 | -80 | N/A |
| 9/30/2022 | 70 | -110 | -95 | -85 | N/A |
| 6/30/2022 | 95 | -98 | -84 | -75 | N/A |
| 3/31/2022 | 103 | -72 | -73 | -66 | N/A |
| 12/31/2021 | 113 | -60 | -61 | -55 | N/A |
| 9/30/2021 | 132 | -58 | -55 | -47 | N/A |
| 6/30/2021 | 124 | -57 | -54 | -45 | N/A |
| 3/31/2021 | 139 | -48 | -59 | -49 | N/A |
| 12/31/2020 | 126 | -52 | -49 | -39 | N/A |
| 9/30/2020 | 98 | -47 | -51 | -43 | N/A |
| 6/30/2020 | 78 | -47 | -52 | -45 | N/A |
| 3/31/2020 | 55 | -52 | -46 | -41 | N/A |
| 12/31/2019 | 48 | -51 | -44 | -40 | N/A |
| 9/30/2019 | 47 | -51 | -44 | -40 | N/A |
| 6/30/2019 | 45 | -48 | -47 | -42 | N/A |
| 3/31/2019 | 44 | -47 | -44 | -39 | N/A |
| 12/31/2018 | 42 | -43 | -45 | -40 | N/A |
| 9/30/2018 | 41 | -39 | -43 | -36 | N/A |
| 6/30/2018 | 40 | -37 | -41 | -34 | N/A |
| 3/31/2018 | 38 | -33 | N/A | -33 | N/A |
| 12/31/2017 | 36 | -31 | N/A | -29 | N/A |
| 12/31/2016 | 30 | -23 | N/A | -25 | N/A |
Toekomstige groeivoorspellingen analisten
Verdiensten versus spaarpercentage: Insufficient data to determine if VAPO's forecast earnings growth is above the savings rate (2.5%).
Winst versus markt: Insufficient data to determine if VAPO's earnings are forecast to grow faster than the US market
Hoge groeiwinsten: Insufficient data to determine if VAPO's earnings are expected to grow significantly over the next 3 years.
Omzet versus markt: Insufficient data to determine if VAPO's revenue is forecast to grow faster than the US market.
Hoge groei-inkomsten: Insufficient data to determine if VAPO's revenue is forecast to grow faster than 20% per year.
Groeiprognoses winst per aandeel
Toekomstig rendement op eigen vermogen
Toekomstige ROE: Insufficient data to determine if VAPO's Return on Equity is forecast to be high in 3 years time